Premarket roundup: Progressive, Amgen

Recs

0

Among the premarket stories for Tuesday, May 20, from AP Financial News:

NEW YORK (AP) _ A Wachovia analyst upgraded Progressive Corp. Tuesday, saying the car insurer's business is improving and the company could make a major announcement at a meeting next month.

NEW YORK (AP) _ Positive study data on Amgen Inc.'s developing osteoporosis treatment could give the biotechnology company a positive boost, though Wall Street had been expecting the results.

NEW YORK (AP) _ A Credit Suisse analyst upgraded three utilities, and downgraded one, Tuesday in a wide-ranging analysis of the power sector that forecasts many companies will post an earnings jump of about 10 percent after 2010.

NEW YORK (AP) _ Rudolph Technologies Inc., which makes equipment used to manufacture semiconductors, is poised to gain from its strong leadership in many markets, according to one analyst.

NEW YORK (AP) _ Shares of Home Depot Inc. wavered in premarket trading Tuesday after the home improvement retailer reported a larger-than-expected fiscal first-quarter profit, but posted weaker sales.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 648527, ~/articles/articlehandler.aspx, 12/2/2008 7:32:56 AM,

Sign up for FREE Motley Fool site access to keep reading:

“Premarket roundup: Progressive, Amgen”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Market Summary

S&P 500816.21 -8.93%
DJIA8,149.09 -7.70%
NASD1,398.07 -8.95%
Updated: 4:04:56 PM
Sponsored by:

Related Tickers

Amgen, Inc.

CAPS Rating 4/5 Stars

$54.77

-0.77 (-1.39%)

Outperform1741

Underperform155

Rate This Stock